Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.135
-0.130 (-10.28%)
Jan 21, 2026, 2:48 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 38.45 million as of January 21, 2026. Its market cap has decreased by -56.45% in one year.
Market Cap
38.45M
Enterprise Value
23.89M
Revenue
36.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.14
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 38.45M, a decrease of -84.37%. That is a compound annual growth rate of -37.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 38.45M | 10.00% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |